Page |
||||
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS IN U.S. DOLLARS ($): |
||||
3-4 | ||||
5 | ||||
6 | ||||
7 | ||||
8-22 |
June 30, 2022 |
December 31, 2021 |
|||||||
U.S. dollars in thousands |
||||||||
Assets |
||||||||
CURRENT ASSETS: |
||||||||
Cash and cash equivalents |
||||||||
Short-term deposits |
||||||||
Trade accounts receivable |
||||||||
Prepaid expenses |
||||||||
Other current assets |
||||||||
Inventories |
||||||||
TOTAL CURRENT ASSETS |
||||||||
LONG-TERM ASSETS: |
||||||||
Property and equipment, net |
||||||||
Operating lease right-of-use assets |
||||||||
Other assets |
||||||||
TOTAL LONG-TERM ASSETS |
||||||||
TOTAL ASSETS |
||||||||
June 30, 2022 |
December 31, 2021 |
|||||||
U.S. dollars in thousands |
||||||||
Liabilities and Shareholders’ Equity |
||||||||
CURRENT LIABILITIES: |
||||||||
Trade accounts payable |
||||||||
Accrued compensation |
||||||||
Current maturities of operating leases liabilities |
||||||||
Other current liabilities |
||||||||
TOTAL CURRENT LIABILITIES |
||||||||
LONG-TERM LIABILITIES: |
||||||||
Forfeiture Shares, |
||||||||
Non-current operating leases liabilities |
||||||||
Other long-term liabilities |
||||||||
TOTAL LONG-TERM LIABILITIES |
||||||||
COMMITMENTS AND CONTINGENT LIABILITIES |
||||||||
TOTAL LIABILITIES |
||||||||
SHAREHOLDERS’ EQUITY: |
||||||||
Ordinary shares, |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
TOTAL SHAREHOLDERS’ EQUITY |
||||||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||
Six months ended June 30 |
Three months ended June 30 |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
U.S. dollars in thousands, except share and per share amounts |
||||||||||||||||
REVENUES |
||||||||||||||||
COST OF REVENUES |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
GROSS PROFIT |
||||||||||||||||
OPERATING EXPENSES: |
||||||||||||||||
Research and development expenses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Sales and marketing expenses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
General and administrative expenses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
TOTAL OPERATING EXPENSES |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
OPERATING LOSS |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Change in fair value of Forfeiture Shares |
||||||||||||||||
Financial income (expenses), net |
( |
) | ( |
) | ||||||||||||
LOSS BEFORE INCOME TAXES |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
INCOME TAXES |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
LOSS AFTER INCOME TAXES |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Equity in earnings of investee |
||||||||||||||||
NET LOSS |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Basic and diluted net loss per ordinary share |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Weighted average number of shares used in computing net loss per ordinary share |
||||||||||||||||
Six months ended June 30, 2022 |
||||||||||||||||||||
Ordinary shares |
Additional paid- in capital |
Accumulated deficit |
Total |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance - January 1, 2022 |
( |
) | ||||||||||||||||||
Exercise of options and RSUs |
— | |||||||||||||||||||
Stock based compensation |
— | — | — | |||||||||||||||||
Net loss for the period |
— | — | — | ( |
) | ( |
) | |||||||||||||
Balance – June 30, 2022 |
( |
) | ||||||||||||||||||
Six months ended June 30, 2021 |
||||||||||||||||||||
Ordinary shares |
Additional paid- in capital |
Accumulated deficit |
Total |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance - January 1, 2021 |
( |
) | ( |
) | ||||||||||||||||
Exercise of options |
— | |||||||||||||||||||
Stock based compensation |
— | — | — | |||||||||||||||||
Net loss for the period |
— | — | — | ( |
) | ( |
) | |||||||||||||
Balance – June 30, 2021 |
( |
) | ( |
) | ||||||||||||||||
Three months ended June 30, 2022 |
||||||||||||||||||||
Ordinary shares |
Additional paid- in capital |
Accumulated deficit |
Total |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance - April 1, 2022 |
( |
) | ||||||||||||||||||
Exercise of options and RSUs |
— | |||||||||||||||||||
Stock based compensation |
— | — | — | |||||||||||||||||
Net loss for the period |
— | — | — | ( |
) | ( |
) | |||||||||||||
Balance - June 30, 2022 |
( |
) | ||||||||||||||||||
Three months ended June 30, 2021 |
||||||||||||||||||||
Ordinary shares |
Additional paid- in capital |
Accumulated deficit |
Total |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance - April 1, 2021 |
( |
) | ( |
) | ||||||||||||||||
Exercise of options |
— | |||||||||||||||||||
Stock based compensation |
— | — | — | |||||||||||||||||
Net loss for the period |
— | — | — | ( |
) | ( |
) | |||||||||||||
Balance - June 30, 2021 |
( |
) | ( |
) | ||||||||||||||||
Six months ended June 30 |
Three months ended June 30 |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
U.S. dollars in thousands |
||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||||||||||
Net loss for the period |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||||||||
Income and expense items not involving cash flows: |
||||||||||||||||
Depreciation |
||||||||||||||||
Stock-based compensation |
||||||||||||||||
Exchange rate differences |
( |
) | ( |
) | ||||||||||||
Interest from short-term deposits |
( |
) | ( |
) | ||||||||||||
Change in fair value of Forfeiture Shares |
( |
) | ( |
) | ||||||||||||
Reduction in the carrying amount of ROU assets |
||||||||||||||||
Changes in operating assets and liabilities: |
||||||||||||||||
Trade accounts receivable |
( |
) | ( |
) | ||||||||||||
Prepaid expenses |
( |
) | ( |
) | ||||||||||||
Other current assets |
||||||||||||||||
Inventories |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Other assets |
( |
) | ( |
) | ||||||||||||
Trade accounts payable |
||||||||||||||||
Accrued compensation |
( |
) | ||||||||||||||
Other current liabilities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Change in operating lease liabilities |
( |
) | ( |
) | ||||||||||||
Other long-term liabilities |
( |
) | ||||||||||||||
Net cash used in operating activities |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||||||||||
Investment in short-term deposits |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Maturities of short-term deposits |
||||||||||||||||
Purchase of property and equipment |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Net cash provided by investing activities |
||||||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||||||||||
Deferred issuance costs |
( |
) | ( |
) | ||||||||||||
Exercise of options |
||||||||||||||||
Net cash provided by financing activities |
||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents |
( |
) | ( |
) | ||||||||||||
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
( |
) |
||||||||||||||
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD |
||||||||||||||||
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD |
||||||||||||||||
SUPPLEMENT DISCLOSURE OF CASH FLOW INFORMATION - |
||||||||||||||||
Cash paid for taxes |
||||||||||||||||
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: |
||||||||||||||||
Trade accounts payable on account on property and equipment |
||||||||||||||||
Unpaid issuance costs |
||||||||||||||||
Operating lease liabilities arising from obtaining operating right-of-use assets |
a. |
Valens Semiconductor Ltd. (hereafter “Valens”, and together with its wholly owned subsidiaries, the “Company”), was incorporated in Israel in 2006. |
b. |
On March 11, 2020, the World Health Organization designated the outbreak of a novel strain of coronavirus (“COVID-19”) as a global pandemic. Governments and businesses around the world have taken unprecedented actions to mitigate the spread of COVID-19, including imposing restrictions on movement and travel such as quarantines and shelter-in-place requirements, and restricting or prohibiting outright some or all commercial and business activity. These measures, though currently temporary in nature, may become more severe and continue indefinitely depending on the evolution of the COVID-19 pandemic. Although there are effective vaccines for COVID-19 that have been approved for use, not all the Company’s employees are vaccinated and specifically not with the booster vaccination. In addition, new strains of the virus have appeared (primarily, and most recently the Omicron variant), which may complicate treatment and vaccination programs. Accordingly, concerns remain regarding additional surges of the pandemic or the expansion of the economic impact thereof, and the extent to which the COVID-19 pandemic may impact the Company’s future results of operations and financial condition. |
c. |
On September 29, 2021 (the “Closing Date”), the Company consummated a merger transaction (referred to as the “Merger Agreement Closing”) pursuant to a merger agreement, dated May 25, 2021 (the “Merger Agreement”), by and among the Company, PTK Acquisition Corp. (“PTK”), a Delaware corporation whose common stock and warrants were then traded on the New York Stock Exchange and Valens Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company. |
d. |
Military Tensions Between Russia and Ukraine |
a. |
Basis of Presentation |
b. |
Lease |
c. |
New Accounting Pronouncements |
June 30, 2022 |
December 31, 2021 |
|||||||
U.S. dollars in thousands |
||||||||
Work in process |
||||||||
Finished goods |
||||||||
For the six months ended on June 30,2022 |
For the three months ended on June 30, 2022 |
|||||||
U.S. dollars in thousands |
||||||||
Operating lease cost: |
||||||||
Fixed Payment |
For the six months ended on June 30,2022 |
For the three months ended on June 30,2022 |
|||||||
U.S. dollars in thousands |
||||||||
Cash paid for amounts included in the measurement of lease liabilities: |
||||||||
Operating cash flows for operating leases |
||||||||
Right-of-use assets obtained in exchange for lease obligations (non-cash): |
||||||||
Operating leases, for initial adoption refer to note 2(c) |
June 30, 2022 |
||||
U.S. dollars in thousands |
||||
Operating lease right-of-use assets |
||||
Current maturities of operating leases |
||||
Non-current operating leases |
||||
Total operating lease liabilities |
||||
Weighted average remaining lease term (years) |
||||
Weighted annual average discount rate |
% | |||
June 30, 2022 |
||||
U.S. dollars in thousands |
||||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Total operating lease payments |
||||
Less: imputed interest |
( |
) | ||
Present value of lease liabilities |
||||
a. |
Noncancelable Purchase Obligations |
b. |
Legal proceedings |
June 30, 2022 |
December 31, 2021 |
|||||||
U.S. dollars in thousands |
||||||||
Accrued vacation |
||||||||
Taxes payable |
||||||||
Accrued expenses- related party |
||||||||
Accrued expenses |
||||||||
a. |
On the Closing Date, |
June 30, 2022 |
December 31, 2021 | |||
Stock price |
||||
Expected term (years) |
||||
Expected volatility |
||||
Risk-free interest rate |
b. |
The table below sets forth a summary of the changes in the fair value of the Forfeiture Shares classified as Level 3: |
Six months ended June 30, 2022 |
Year ended December 31, 2021 |
|||||||
U.S. dollars in thousands |
||||||||
Balance at beginning of period |
||||||||
Issuance of Forfeiture Shares |
||||||||
Changes in fair value |
( |
) | ||||||
Balance at end of the period |
||||||||
Six months ended June 30, 2022 |
||||||||
Number of Options |
Weighted- Average Exercise price |
|||||||
Options outstanding as of December 31, 2021 |
$ | |||||||
Granted during the period |
$ | |||||||
Exercised during the period |
( |
) | $ | |||||
Forfeited during the period |
( |
) | $ | |||||
Options outstanding as of June 30, 2022 |
$ | |||||||
Options exercisable as of June 30, 2022 |
$ | |||||||
Outstanding as of June 30, 2022 |
Exercisable as of June 30, 2022 |
|||||||||||||||||||||||||||||||||
Range of exercise prices |
Number outstanding |
Weighted average remaining contractual term |
Weighted average exercise price |
Aggregate intrinsic value (U.S. dollars in thousands) |
Number Exercisable |
Weighted average remaining contractual term |
Weighted Average exercise price |
Aggregate intrinsic value (U.S. dollars in thousands) |
||||||||||||||||||||||||||
$ |
$ | $ | ||||||||||||||||||||||||||||||||
$ |
$ | $ | ||||||||||||||||||||||||||||||||
$ |
$ | $ | ||||||||||||||||||||||||||||||||
$ |
$ | — | — | — | — | — | ||||||||||||||||||||||||||||
$ |
$ | — | $ | — | ||||||||||||||||||||||||||||||
$ |
$ | — | $ | — |
For the Six months ended on June 30,2022 |
For the six months ended on June 30 2021 | |||
Expected term |
||||
Expected volatility |
||||
Expected dividend rate |
||||
Risk-free rate |
Six months ended June 30 |
Three months ended June 30 |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
U.S. dollars in thousands |
||||||||||||||||
Cost of revenue |
( |
) | ||||||||||||||
Research and development |
||||||||||||||||
Selling, general and administrative |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total stock-based compensation |
||||||||||||||||
|
|
|
|
|
|
|
|
Six months ended June 30, 2022 |
||||||||
Number of RSUs |
Weighted- Average Grant Date Fair Value |
|||||||
RSUs outstanding at the beginning of the year |
$ | |||||||
Granted during the period |
$ | |||||||
Exercised during the period |
( |
) | $ | |||||
Forfeited during the period |
( |
) | $ | |||||
|
|
|||||||
Outstanding at the end of the period |
$ | |||||||
|
|
|||||||
RSUs exercisable at June 30, 2022 |
||||||||
|
|
Outstanding as of June 30, 2022 |
Exercisable as of June 30, 2022 |
|||||||||||||||||||||||||||||||||
Range of exercise prices |
Number outstanding |
Weighted average remaining contractual term |
Weighted average exercise price |
Aggregate intrinsic value (U.S. dollars in thousands) |
Number Exercisable |
Weighted average remaining contractual term |
Weighted Average exercise price |
Aggregate intrinsic value (U.S. dollars in thousands) |
||||||||||||||||||||||||||
$ |
$ | $ | — | — | — | — | ||||||||||||||||||||||||||||
$ |
$ | $ | — | — | — | — | ||||||||||||||||||||||||||||
$ |
$ | $ | — | — | — | — | ||||||||||||||||||||||||||||
$ |
$ | $ | — | — | — | — |
Six months ended June 30 |
Three months ended June 30 |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
U.S. dollars in thousands |
||||||||||||||||
Cost of revenue |
— | — | ||||||||||||||
Research and development |
— | — | ||||||||||||||
Selling, general and administrative |
— | — | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total stock-based compensation- RSUs |
— |
— |
||||||||||||||
|
|
|
|
|
|
|
|
Six months ended |
Three months ended |
|||||||||||||||
June 30, 2022 |
June 30, 2021 |
June 30, 2022 |
June 30, 2021 |
|||||||||||||
Basic net loss per ordinary share |
||||||||||||||||
Numerator: |
||||||||||||||||
Net loss from continuing operations |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Dividend on Series E Redeemable Preferred |
— | ( |
) | — | ( |
) | ||||||||||
Dividend on Series D Redeemable Preferred |
— | ( |
) | — | ( |
) | ||||||||||
Dividend on Series C Redeemable Preferred |
— | ( |
) | — | ( |
) | ||||||||||
Dividend on Series B-2 Redeemable Preferred |
— | ( |
) | — | ( |
) | ||||||||||
Dividend on Series B-1 Redeemable Preferred |
— | ( |
) | — | ( |
) | ||||||||||
Dividend on Series A Redeemable Preferred |
— | ( |
) | — | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Numerator for basic and diluted net loss per common share – net loss attributable to common stockholders |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Denominator: |
||||||||||||||||
Denominator for basic and dilutive net loss per common share- adjusted weighted-average share |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and dilutive net loss per common share |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|
|
Six months ended |
Three months ended |
|||||||||||||||
June 30, 2022 |
June 30, 2021 |
June 30, 2022 |
June 30, 2021 |
|||||||||||||
Options |
||||||||||||||||
Restricted Stock Units |
— | — | ||||||||||||||
Warrants liability |
— | — | — | |||||||||||||
Private Warrants |
— | — | ||||||||||||||
Public Warrants |
— | — | ||||||||||||||
Forfeiture Shares |
— | — | ||||||||||||||
Redeemable convertible Preferred A shares |
— | — | ||||||||||||||
Redeemable convertible Preferred B-1 shares |
— | — | ||||||||||||||
Redeemable convertible Preferred B-2 shares |
— | — | ||||||||||||||
Redeemable convertible Preferred C shares |
— | — | ||||||||||||||
Redeemable convertible Preferred D shares |
— | — | ||||||||||||||
Redeemable convertible Preferred E shares |
— | — |
Six months ended June 30 |
Three months ended June 30 |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
U.S. dollars in thousands |
||||||||||||||||
Foreign currency exchange differences |
( |
) | ( |
) | ||||||||||||
Interest income on short-term deposits |
||||||||||||||||
Other |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Total financial income (expenses), net |
( |
) |
( |
) |
||||||||||||
a. |
For the purpose of evaluating financial performance and allocating resources, the CODM reviews financial information presented on a consolidated basis accompanied by disaggregated information about revenues, gross profit and operating loss by the two identified reportable segments, to make decisions about resources to be allocated to the segments and assess their performance. Assets information is not provided to the CODM and is not being reviewed. Revenues and cost of goods sold are directly associated with the activities of a specific segment. Direct operating expenses, including general and administrative expenses, associated with the activities of a specific segment are charged to that segment. |
Six months ended on June 30, 2022 |
||||||||||||
Audio- Video |
Automotive |
Consolidated |
||||||||||
U.S. dollars in thousands |
||||||||||||
Revenues |
||||||||||||
Gross profit |
||||||||||||
Research and development expenses |
||||||||||||
Sales and marketing expenses |
||||||||||||
General and administrative expenses |
||||||||||||
Segment operating profit (loss) |
( |
) | ( |
) | ||||||||
Change in fair value of Forfeiture Shares |
||||||||||||
Financial expenses, net |
( |
) | ||||||||||
Loss before taxes on income |
( |
) | ||||||||||
Depreciation expenses |
||||||||||||
Six months ended on June 30, 2021 |
||||||||||||
Audio- Video |
Automotive |
Consolidated |
||||||||||
U.S. dollars in thousands |
||||||||||||
Revenues |
||||||||||||
Gross profit |
||||||||||||
Research and development expenses |
||||||||||||
Sales and marketing expenses |
||||||||||||
General and administrative expenses |
||||||||||||
Segment operating profit (loss) |
( |
) | ( |
) | ||||||||
Financial expenses, net |
||||||||||||
Loss before taxes on income |
( |
) | ||||||||||
Depreciation expenses |
||||||||||||
Three months ended on June 30, 2022 |
||||||||||||
Audio- Video |
Automotive |
Consolidated |
||||||||||
U.S. dollars in thousands |
||||||||||||
Revenues |
||||||||||||
Gross profit |
||||||||||||
Research and development expenses |
||||||||||||
Sales and marketing expenses |
||||||||||||
General and administrative expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Segment operating profit (loss) |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Change in fair value of Forfeiture Shares |
||||||||||||
Financial expenses, net |
( |
) | ||||||||||
|
|
|||||||||||
Loss before taxes on income |
( |
) | ||||||||||
|
|
|||||||||||
Depreciation expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Three months ended on June 30, 2021 |
||||||||||||
Audio- Video |
Automotive |
Consolidated |
||||||||||
U.S. dollars in thousands |
||||||||||||
Revenues |
||||||||||||
Gross profit |
||||||||||||
Research and development expenses |
||||||||||||
Sales and marketing expenses |
||||||||||||
General and administrative expenses |
||||||||||||
|
|
|
|
|
|
|||||||
Segment operating profit (loss) |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
Change in fair value of Forfeiture Shares |
||||||||||||
Financial expenses, net |
||||||||||||
|
|
|||||||||||
Loss before taxes on income |
( |
) | ||||||||||
|
|
|||||||||||
Depreciation expenses |
||||||||||||
|
|
|
|
|
|
b. |
Geographic Revenues |
Six months ended June 30 |
Three months ended June 30 |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
U.S. dollars in thousands |
||||||||||||||||
Israel |
||||||||||||||||
China |
||||||||||||||||
United States |
||||||||||||||||
Hong Kong |
||||||||||||||||
Hungary |
||||||||||||||||
Japan |
||||||||||||||||
Other |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
|
|
|
|
|
|
|
|
c. |
Supplemental data - Major Customers: |
June 30, 2022 |
December 31, 2021 |
|||||||
Accounts Receivable |
U.S. dollars in thousands |
|||||||
Customer A |
% | % | ||||||
Customer B |
% | % | ||||||
Customer C |
% | % |
Six months ended June 30, |
Three months ended June 30, |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
Revenues |
U.S. dollars in thousands |
U.S. dollars in thousands |
||||||||||||||
Customer D |
% | % | % | % | ||||||||||||
Customer A |
% | % | % | % | ||||||||||||
Customer E |
% | % | % | % | ||||||||||||
Customer F |
% | % | % | % | ||||||||||||
Customer G |
% | % | % | % |
d. |
Property and Equipment by Geography: |
June 30, 2022 |
December 31, 2021 |
|||||||
U.S. dollars in thousands |
||||||||
Domestic (Israel) |
||||||||
Taiwan |
||||||||
China |
||||||||
USA |
||||||||
|
|
|
|
|||||